We are a clinical stage biopharmaceutical company, focused on the development and commercialization of novel therapeutics and innovative approaches aimed at intercepting and preventing immune-mediated diseases.
Last Closing Price
January 14, 2021
LEERINK SWANN & COMPANY
This offering is no longer available
Sign Up to participate in future offerings
To view the prospectus for Provention Bio, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277